Grendel Alvarado and Jenilyn Olivar Disqualified From Bb. Pilipinas 2011 Pageant; BPCI Announces the 38 Official …
Grendel Alvarado and Jenilyn Olivar Disqualified From Bb. Pilipinas 2011 Pageant; BPCI Announces the 38 Official …
Binibining Pilipinas 2011 candidates Grendel Alvarado and Jenilyn ‘Jen’ Olivar have been disqualified from the pageant due to a naked photoshoot they did when they joined Philippines’ Next Top Model in 2007 where Grendel was the winner while Jen placed as 2nd Runner Up. ( L-R: Grender Alvarado and Jenilyn Olivar photo shoot for Philippines’ Next Top Model 2007 ) The photoshoot happened during …
Read more on Showbiz Nest
Categories: Breast Cancer Awareness Tags: 2011, Alvarado, Announces, BPCI, Disqualified, From, Grendel, Jenilyn, official, Olivar, Pageant, Pilipinas
Pacific Life Foundation Announces $2.75 Million in Grants to Nearly 200 Nonprofit Agencies in Southern California …
Pacific Life Foundation Announces $2.75 Million in Grants to Nearly 200 Nonprofit Agencies in Southern California …
The Pacific Life Foundation announced $2.75 million in grants, ranging from $5,000 to $100,000, to nearly 200 nonprofit agencies serving Southern California during an early Monday evening reception.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Organizations Tags: $2.75, Agencies, Announces, California, Foundation, Grants, Life, million, Nearly, nonprofit, Pacific, Southern
ARUP Laboratories Announces Availability of a New Laboratory Developed Test for Subtyping Breast Cancer
ARUP Laboratories Announces Availability of a New Laboratory Developed Test for Subtyping Breast Cancer
SALT LAKE CITY–(BUSINESS WIRE)–ARUP Laboratories offers a new assay based on the PAM50 gene signature designed to diagnose different breast cancer subtypes and determine other tumor characteristics important for patient management.
Read more on Business Wire
Categories: Breast Cancer Information Tags: Announces, ARUP, Availability, breast, cancer, Developed, Laboratories, Laboratory, Subtyping, test
Watson Announces Novel Oral Contraceptive Approval
Watson Announces Novel Oral Contraceptive Approval
Watson Pharmaceuticals today announced the U.S. Food and Drug Administration approval of a novel oral contraceptive product â the first and only low dose oral contraceptive to combine 0.8 mg norethindrone and 0.025 mg ethinyl estradiol in chewable form, with four 75 mg ferrous fumarate placebo tablets.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Information Tags: Announces, Approval, Contraceptive, novel, Oral, Watson
Cyclacel Announces Topline Results From the Appraise Phase 2b Study of Seliciclib in Heavily-Pretreated Patients With …
Cyclacel Announces Topline Results From the Appraise Phase 2b Study of Seliciclib in Heavily-Pretreated Patients With …
BERKELEY HEIGHTS, N.J. — Cyclacel Pharmaceuticals, Inc. , a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today topline results from APPRAISE, the Company’s Phase 2b, randomized discontinuation, double-blinded, placebo-controlled, study of oral seliciclib capsules as a …
Read more on GlobeNewswire via Yahoo! Finance
Categories: Breast Cancer Information Tags: Announces, Appraise, Cyclacel, From, HeavilyPretreated, Patients, Phase, Results, Seliciclib, Study, Topline